Download Files:
Products Details
Product Description
– KRAS G12C inhibitor 37 is a potent inhibitor of KRAS G12C. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS G12C inhibitor 37 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent WO2018143315A1, compound 65)[1].
Web ID
– HY-143590
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C35H39F3N8O2
References
– [1]Quinazoline compound. Patent WO2018143315A1.
CAS Number
– 2241720-04-5
Molecular Weight
– 660.73
SMILES
– C=CC(N1CC2(C1)CCN(CC2)C3=NC(N4CC(C4)N(C)C)=NC5=C(C(C6=C7C=NNC7=CC=C6C)=C(C=C35)C=C)OCC(F)(F)F)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Ras
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
